Logo společnosti SOTIO Biotech

Scientist

SOTIO Biotech

Typ práce
Plný úvazek
Lokalita
Praha
Scientist ️ Logo společnosti SOTIO Biotech

The Department of Research and Science of a mid-sized biotech company Sotio based in Prague, is looking for a scientist to join a research team focused on the tumor microenvironment of HPV-induced malignancies.

Position Summary:

Your role will be to analyze the tumor microenvironment of cancer samples obtained from patients with HPV-associated malignancies. Methods used in our projects include flow cytometry, high-plex immunofluorescence, immunohistochemistry, spatial transcriptomics, and quantitative image analysis using Halo software. The role also involves the optimization of new panels and the implementation of new methods.

Key Activities and Responsibilities:

  • Stain and analyze fresh and FFPE tumor samples

  • Design and optimize new experiments

  • Analyze data in FlowJo and Halo software

  • Help to establish spatial transcriptomic analyses of tumor tissues using 10x technology (Xenium)

  • Present data on lab meetings and scientific conferences

Competences, Skills and Qualification:

  • Master’s/PhD degree in immunology/molecular biology or similar field

  • At least 3 years of experience in a wet lab

  • Deep interest in cancer immunology

  • Proficient language skills in written and oral English (at least B2 level)

  • Ability to summarize and present obtained data

  • Solid skills in the use of MS Office (Excel, Word, PowerPoint, Outlook)

  • Ability to work in a team and willingness to assume responsibility for successful completion of tasks

Location:

Harfa Business Center – B, Českomoravská 2532/19b, 190 00 Prague 9, Czech Republic

O pracovní pozici

Obor:
Věda a výzkum
Profese:
Vědecko výzkumný pracovník
Typ práce:
Plný úvazek
Určeno pro:
Kohokoliv
Poslední aktualizace:
Lokalita:
Praha

SOTIO Biotech

Logo společnosti SOTIO Biotech

SOTIO Biotech is part of investment group PPF. SOTIO is shaping the future of cancer immunotherapies by translating compelling science into patient benefit Our robust clinical pipeline includes a differentiated superagonist of the attractive immun…